The Legislature website will be intermittently unavailable from 7AM to 7PM, Saturday, October 24 for scheduled maintenance. We apologize for the inconvenience.
(1) The commission identifies the following as an over-the-counter drug in Washington:
(a) 4 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product.
(b) 3 mg naloxone hydrochloride nasal spray, approved by the FDA for marketing as an OTC drug product.
(2) Any conflicts between this section and the publications incorporated by reference in WAC 246-945-030(2) should be resolved in favor of this section.